CN103385886B - Houttuynoid E在制备治疗或预防急性心衰的药物中的应用 - Google Patents
Houttuynoid E在制备治疗或预防急性心衰的药物中的应用 Download PDFInfo
- Publication number
- CN103385886B CN103385886B CN201310253717.2A CN201310253717A CN103385886B CN 103385886 B CN103385886 B CN 103385886B CN 201310253717 A CN201310253717 A CN 201310253717A CN 103385886 B CN103385886 B CN 103385886B
- Authority
- CN
- China
- Prior art keywords
- heart failure
- houttuynoid
- acute heart
- medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VCNWTZPWIVDHGN-SLBJRTIWSA-N 2-[4,5-dihydroxy-2-(2-oxoundecyl)phenyl]-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound CCCCCCCCCC(=O)CC1=CC(O)=C(O)C=C1C1=C(O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 VCNWTZPWIVDHGN-SLBJRTIWSA-N 0.000 title claims abstract description 36
- 206010007556 Cardiac failure acute Diseases 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 230000002265 prevention Effects 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 230000000747 cardiac effect Effects 0.000 description 6
- 208000009889 Herpes Simplex Diseases 0.000 description 4
- 241000700584 Simplexvirus Species 0.000 description 4
- 230000003602 anti-herpes Effects 0.000 description 4
- 241000282465 Canis Species 0.000 description 3
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 229930190556 houttuynoid Natural products 0.000 description 3
- 229960002275 pentobarbital sodium Drugs 0.000 description 3
- 240000000691 Houttuynia cordata Species 0.000 description 2
- 235000013719 Houttuynia cordata Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310253717.2A CN103385886B (zh) | 2013-06-24 | 2013-06-24 | Houttuynoid E在制备治疗或预防急性心衰的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310253717.2A CN103385886B (zh) | 2013-06-24 | 2013-06-24 | Houttuynoid E在制备治疗或预防急性心衰的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103385886A CN103385886A (zh) | 2013-11-13 |
CN103385886B true CN103385886B (zh) | 2015-08-19 |
Family
ID=49530421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310253717.2A Active CN103385886B (zh) | 2013-06-24 | 2013-06-24 | Houttuynoid E在制备治疗或预防急性心衰的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103385886B (zh) |
-
2013
- 2013-06-24 CN CN201310253717.2A patent/CN103385886B/zh active Active
Non-Patent Citations (1)
Title |
---|
"Houttuynoid A-E,Anti-Herpes Simplex Virus Active Flavonoids with Novel Skeletons from Houttuynia cordata";Chen,S.D.et al;《Organic Letters》;20120430;第14卷(第7期);1772-1775 * |
Also Published As
Publication number | Publication date |
---|---|
CN103385886A (zh) | 2013-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103356669B (zh) | Houttuynoid A在制备治疗或预防急性心衰的药物中的应用 | |
CN103655549B (zh) | Myrtucommuacetalone在治疗或预防急性心衰药物中的应用 | |
CN103372007B (zh) | Chukrasone B在制备治疗或预防急性心衰的药物中的应用 | |
CN103385886B (zh) | Houttuynoid E在制备治疗或预防急性心衰的药物中的应用 | |
CN103356683B (zh) | Houttuynoid C在制备治疗或预防急性心衰的药物中的应用 | |
CN103356677B (zh) | Houttuynoid D在制备治疗或预防急性心衰的药物中的应用 | |
CN103356675B (zh) | Houttuynoid B在制备治疗或预防急性心衰的药物中的应用 | |
CN103393661A (zh) | Sarcaboside A在治疗或预防急性心衰的药物中的应用 | |
CN105497039A (zh) | Trigonoliimines C在制备治疗或预防急性心衰药物中的应用 | |
CN105168191A (zh) | 一种治疗或预防急性心衰药物及其应用 | |
CN103751179B (zh) | 一种化合物在治疗或预防急性心衰药物中的应用 | |
CN102861034B (zh) | Gypensapogenin A在治疗或预防急性心衰的药物中的应用 | |
CN103622964B (zh) | Trigolutesins A在治疗或预防急性心衰药物中的应用 | |
CN102885836B (zh) | Gypensapogenin B在制备治疗或预防急性心衰的药物中的应用 | |
CN103494824B (zh) | Kadcoccitones A在制备治疗或预防急性心衰药物中的应用 | |
CN103751176B (zh) | Trigoxyphin K在治疗或预防急性心衰药物中的应用 | |
CN105287503A (zh) | Foveolide A在治疗或预防急性心衰药物中的应用 | |
CN105287504A (zh) | Irciniastatin B在制备治疗或预防急性心衰药物中的应用 | |
CN103381166A (zh) | Chukrasone A在治疗或预防急性心衰的药物中的应用 | |
CN103356529A (zh) | Sarcaboside B在制备治疗或预防急性心衰的药物中的应用 | |
CN105395537A (zh) | Vulgarisin A在治疗或预防急性心衰药物中的应用 | |
CN103120670A (zh) | Eryngiolide A在治疗或预防急性心衰的药物中的应用 | |
CN105412081A (zh) | Penicillactones A在制备治疗或预防急性心衰药物中的应用 | |
CN102988344A (zh) | Aphanamixoid A在制备治疗或预防急性心衰的药物中的应用 | |
CN106265688A (zh) | Friedolanostanes在治疗或预防急性心衰药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171115 Address after: 401120 Chongqing Yubei District Food City Avenue 18 Chongqing advertising industrial park office space Patentee after: Chongqing San Mou science and Technology Development Co., Ltd. Address before: 210009 Gulou District, Jiangsu, Nanjing Gu Ping Kong, No. 4 Patentee before: Ding Shengyu |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191227 Address after: 200120 No.2, Lane 188, Banxia Road, Pudong New Area, Shanghai Patentee after: Jichuan (Shanghai) Medical Technology Co., Ltd Address before: 401120 Chongqing Yubei District Food City Avenue 18 Chongqing advertising industrial park office space Patentee before: Chongqing San Mou science and Technology Development Co., Ltd. |